Abstract:Breast cancer is the most prevalent cancer worldwide, affecting both low- and middle-income countries, with a growing number of cases. In 2024, about 310,720 women in the U.S. are projected to receive an invasive breast cancer diagnosis, alongside 56,500 cases of ductal carcinoma in situ (DCIS). Breast cancer occurs in every country of the world in women at any age after puberty but with increasing rates in later life. About 65% of women with the BRCA1 and 45% with the BRCA2 gene variants develop breast cancer by age 70. While these genes account for 5% of breast cancers, their prevalence is higher in certain populations. Advances in early detection, personalised medicine, and AI-driven diagnostics are improving outcomes by enabling a more precise analysis, reducing recurrence, and minimising treatment side effects. Our paper aims to explore the vast applications of artificial intelligence within the diagnosis and treatment of breast cancer and how these advancements can contribute to elevating patient care as well as discussing the potential drawbacks of such integrations into modern medicine. We structured our paper as a non-systematic review and utilised Google Scholar and PubMed databases to review literature regarding the incorporation of AI in the diagnosis and treatment of non-palpable breast masses. AI is revolutionising breast cancer management by enhancing imaging, pathology, and personalised treatment. In imaging, AI can improve the detection of cancer in mammography, MRIs, and ultrasounds, rivalling expert radiologists in accuracy. In pathology, AI enhances biomarker detection, improving HER2 and Ki67 assessments. Personalised medicine benefits from AI's predictive power, aiding risk stratification and treatment response. AI also shows promise in triple-negative breast cancer management, offering better prognosis and subtype classification. However, challenges include data variability, ethical concerns, and real-world validation. Despite limitations, AI integration offers significant potential in improving breast cancer diagnosis, prognosis, and treatment outcomes.

AI-enhanced breast imaging: Where are we and where are we heading?

New Frontiers in Breast Cancer Imaging: The Rise of AI

AI Applications to Breast MRI: Today and Tomorrow

Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction

Current status and prospects of breast cancer imaging-based diagnosis using artificial intelligence

Artificial Intelligence Applications in Breast Imaging: Current Status and Future Directions

How Radiomics Can Improve Breast Cancer Diagnosis and Treatment

Radiomics and artificial intelligence in breast imaging: a survey

Artificial Intelligence in Breast Ultrasound: From Diagnosis to Prognosis—A Rapid Review

Empowering breast cancer diagnosis and radiology practice: advances in artificial intelligence for contrast-enhanced mammography

Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence

Artificial Intelligence (AI) in Breast Imaging: A Scientometric Umbrella Review

Artificial Intelligence in Breast Cancer Diagnosis and Treatment: Advances in Imaging, Pathology, and Personalized Care

Emerging uses of artificial intelligence in breast and axillary ultrasound

Artificial Intelligence in Breast Ultrasound: The Emerging Future of Modern Medicine

Artificial intelligence, machine learning, computer-aided diagnosis, and radiomics: advances in imaging towards to precision medicine

Deep Learning in Breast Cancer Imaging: State of the Art and Recent Advancements in Early 2024

Artificial intelligence and interpretations in breast cancer imaging

Artificial intelligence in cancer imaging: Clinical challenges and applications

A narrative review on current imaging applications of artificial intelligence and radiomics in oncology: focus on the three most common cancers

Artificial Intelligence in Medical Imaging of the Breast